semaglutide linked to cancer GLP-1 drugs and cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up 50% less likely Engineering - Recent reports have

Despite the rejection, CMS has indicated that it might cover obesity medication in future rulemaking

For most patients at 0.5 mg who have not achieved treatment goals, the appropriate next step is increasing to 1 mg weekly after at least four weeks at the current dose, provided the medication is well-tolerated

References: Davies M, et al

This is perfectly fine

All three medications help the pancreas release insulin when blood sugar is high and stop glucagon, which prevents the liver from adding more sugar to the blood

It's important to note that compounded semaglutide should use the base form, not salt forms, as these are not equivalent to FDA-approved semaglutide